MERRIMACK PHARMACEUTICALS IN's ticker is MACK and the CUSIP is 590328209. A total of 55 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $169,000 | -65.1% | 27,968 | -59.8% | 0.00% | -63.6% |
Q1 2019 | $484,000 | +52.2% | 69,630 | -15.4% | 0.01% | +37.5% |
Q4 2018 | $318,000 | +71.9% | 82,289 | +132.4% | 0.01% | +100.0% |
Q3 2018 | $185,000 | -35.5% | 35,406 | -39.3% | 0.00% | -33.3% |
Q2 2018 | $287,000 | -23.9% | 58,330 | +24.5% | 0.01% | -25.0% |
Q1 2018 | $377,000 | – | 46,846 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Standard LLC | 869,354 | $2,895,000 | 3.47% |
22NW, LP | 1,241,896 | $4,136,000 | 2.24% |
Newtyn Management, LLC | 1,199,606 | $3,995,000 | 1.46% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 186,198 | $620,000 | 0.35% |
Yakira Capital Management, Inc. | 66,934 | $223,000 | 0.10% |
Sepio Capital, LP | 210,534 | $701,000 | 0.08% |
Nantahala Capital Management | 747,635 | $2,490,000 | 0.08% |
Watson Rebecca | 3,068 | $10,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 61,700 | $205,000 | 0.00% |
WEBSTER BANK, N. A. | 3,055 | $10,000 | 0.00% |